VLP Therapeutics to Develop Malaria Vaccine Under Army Grant; Wataru Akahata Comments
VLP Therapeutics has received a $2.4 million grant from the U.S. Army to research and develop a vaccine against malaria. The service branch awarded the research grant through the Defense Department’s Peer Reviewed Medical Research Program, the company said Thursday. Wataru Akahata, founder and CEO of VLP Therapeutics, said the company has developed VLPM01, an experimental […] More